Catalent, a global provider of oral, injectable and respiratory drug delivery technologies, announced terms for its IPO on Friday. The Somerset, NJ-based company plans to raise $871 million by offering 42.5 million shares at a price range of $19 to $22. At the midpoint of the proposed range, Catalent would command a fully diluted market value of $2.5 billion.
Help employers find you! Check out all the jobs and post your resume.
